19 Glaucoma - Tips, consejos y experiencias BIBLIOGRAFÍA 1. Piette SD, Sergott RC. Pathological optic-disc cupping. Curr Opin Ophthalmol. 2006 Feb;17(1):1-6. 2. Rieck J. The pathogenesis of glaucoma in the interplay with the immune system. Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2393-409. 3. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normaltension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998 Oct;126(4):498-505. 4. The AGIS Investigators. The advanced glaucoma intervention study, 6: effect of cataract on visual field and visual acuity. The AGIS Investigators. Arch Ophthalmol. 2000 Dec;118(12):1639-52. 5. Weinreb RN, Friedman DS, Fechtner RD, Cioffi GA, Coleman AL, Girkin CA, Liebmann JM, Singh K, Wilson MR, Wilson R, Kannel WB. Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol. 2004 Sep;138(3):458-67. 6. Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefánsson E. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002 Jul;21(4):359-93. 7. Halpern DL, Grosskreutz CL. Glaucomatous optic neuropathy: mechanisms of disease. Ophthalmol Clin North Am. 2002 Mar;15(1):61-8. 8. Roy Chowdhury U, Fautsch MP. Intracranial Pressure and Its Relationship to Glaucoma: Current Understanding and Future Directions. Med Hypothesis Discov Innov Ophthalmol. 2015;4(3):71-80. 9. Fleischman D, Allingham RR. The role of cerebrospinal fluid pressure in glaucoma and other ophthalmic diseases: A review. Saudi J Ophthalmol. 2013 Apr;27(2):97-106. 10.Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci. 2008;49(12):5412–5418. 11. Liu KC, Fleischman D, Lee AG, Killer HE, Chen JJ, Bhatti MT. Current concepts of cerebrospinal fluid dynamics and the translaminar cribrosa pressure gradient: a paradigm of optic disk disease. Surv Ophthalmol. 2020 Jan-Feb;65(1):48-66. 12.European Glaucoma Prevention Study (EGPS) Group, Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007 Jan;114(1):3-9. 13.Costa VP, Harris A, Anderson D, Stodtmeister R, Cremasco F, Kergoat H, Lovasik J, Stalmans I, Zeitz O, Lanzl I, Gugleta K, Schmetterer L. Ocular perfusion pressure in glaucoma. Acta Ophthalmol. 2014 Jun;92(4): e252-66. 14. Caprioli J. Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmol Scand. 1997 Aug;75(4):364-7. 15. Chang EE, Goldberg JL. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012 May;119(5):979-86. 16. Caprioli J, Coleman AL; Blood Flow in Glaucoma Discussion. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010 May;149(5):704-12. 17.Harris A, Siesky B, Wirostko B. Cerebral blood flow in glaucoma patients. J Glaucoma. 2013 Jun-Jul;22 Suppl 5(0 5):S46-8. 18.Martinez A, Sanchez M. Ocular blood flow in glaucoma. Br J Ophthalmol. 2008;92:301–1302. 19.Opere CA, Heruye S, Njie-Mbye YF, Ohia SE, Sharif NA. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37:3483-93. 20.Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115:497-503. 21.Liu B, Neufeld AH. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia. 2000;30:178–86.
RkJQdWJsaXNoZXIy MTYwMjk1